Elly De Bruyn: QbD Group Quiz Supports the World Federation of Hemophilia
Elly De Bruyn, Partner and CHRO at QbD Group, shared QbD Group‘s post on LinkedIn:
“Our annual QbD Group quiz took place once again!
A great tradition not only celebrates our JPEG values and winning mentality, but also supports our QbD Foundation.
This year, all proceeds from participation will go to the World Federation of Hemophilia.
A special thank you to Henrik De Backer (our quiz master), Carmen Veys (QbD Foundation member and organiser), Hannah Dreesen (QbD Foundation member, host and organiser), our jury and, of course, all participants who joined us that evening!
Another great example of how we bring our values to life while making a difference together!”
QbD Group shared a post on LinkedIn:
“This month our yearly QbD quiz took place, and what a turnout: 24 teams fighting for the title of QbD Quiz Winner 2026.
The quiz is one of those traditions we look forward to every year. Good food, a few drinks, and colleagues who suddenly get very competitive once the first question is read out.
Thank you, Henrik, for being our quizmaster again, and a big congratulations to the winners!”
See more in the Gallery.
Stay updated with Hemostasis today.
-
Oct 31, 2026, 11:04Abhivandan Nagia: The Expanding Clinical Pipeline in Hemophilia A
-
Oct 31, 2026, 10:54Bartosz Puła: New Advances in Hematology Featured in Acta Haematologica Polonica
-
Oct 31, 2026, 10:47Abhishek Kumar: Amplifying Patient Voices to Transform Haemophilia Care in Bihar
-
Oct 31, 2026, 10:42Josa Hanzlik: The Impact of Double Red Cell Donation
-
Oct 31, 2026, 09:10Alberto F. Chambi: Stroke and Cerebral Venous Thrombosis at High Altitude
-
Oct 31, 2026, 08:52Julianna Argueta: ATHN Data Summit – Advancing Collaboration in Blood Disorders
-
Oct 31, 2026, 08:11Paul Kariuki: Expanding Access to Plasma-Derived Medicines Across Africa
-
Oct 31, 2026, 07:09Akshay Sharma: Gene therapy for sickle cell disease
-
Oct 31, 2026, 07:00Owen McCarty: The Hidden Immune Mechanism Behind Chemotherapy-Associated Platelet Loss